discharge from the first hospitalization listing a splenectomy from the date of the first hospitalization listing a diagnosis of infection, thromboembolism, or malignancy.
Dates of death were ascertained from record linkage to Social Security Administration mortality files. With such a linkage, death reporting is believed to be 96% complete. 36 Among the 8,149 splenectomized men who were selected for study, 6,731 were eligible for matching to the National Death Index (NDI) (alive as of January 1, 1979) . In addition, a random sample (n=6,731) of the eligible VA cohort was selected to match these patients on race and year of birth (1:1 sample). NDI provided death certificate matching for the men who had undergone splenectomy and for the matched controls (n=13,462).
Statistical analysis
Relative risk (RR) estimates and 95% confidence intervals (CI) were calculated using time--dependent Poisson regression methods for cohort data. 37 Calculations were performed using the AMFIT program (Epicure Version 2.0; HiroSoft International Corporation, Seattle, Washington). All risk estimates were adjusted for attained age (<40, 40--49, 50--59, 60--69, 70--79, 80 or more years) and calendar year (1969--1974, 1975--1979, 1980--1984, 1985--1989, 1990--1996) , race (African American or white), number of hospital visits (1--2, 3--4, 5 or more), and time between study entry and exit (2--3, 4--5, 6--9, 10--14, 15 or more years). Risk estimates for buccal, esophagus, and liver cancers were also adjusted for a hospital discharge diagnosis of alcohol related disorders because inclusion of this variable in the regression models resulted in a >10% change in the risk estimates. Adjustment for a hospital discharge diagnosis of hypertension was necessary for the kidney cancer analysis. No other diagnoses were found to materially (>10%) change the risk estimates for the other outcomes. All P values and confidence intervals were two--sided, and P values <0.05 were considered statistically significant. We conducted sensitivity analyses when numbers allowed (>5 exposed cases). Analyses were stratified by race, age at splenectomy/entry (<50, 50+), calendar year at splenectomy/entry (1969--1979, 1980--1996) , latency (2--5 years, 5+), and subsets of patients with only trauma or no autoimmune conditions (as in previous splenectomy studies). 1.76-1.97 RR* models adjusted for attained age and calendar time, latency, race and number of visits. All study subjects were followed from one year after their initial hospital discharge until the first discharge diagnosis of infection, thromboembolism, death, or end of study, whichever occurred first. The time to develop infection, thromboembolism, or malignancy (i.e., latency) was estimated by subtracting the date of discharge from the first hospitalization listing a splenectomy from the date of the first hospitalization listing a diagnosis of infection, thromboembolism, or malignancy. To minimize the influence of reverse causality (i.e., undetected cancer requiring the splenectomy), all analyses were restricted to individuals with their first VA discharge with a splenectomy at least 1 year prior to the first hospitalization listing a diagnosis of cancer. Abbreviations: RR=relative risk; CI=confidence intervals 25 RR* models adjusted for attained age and calendar time, latency, race and number of visits. All study subjects were followed from one year after their initial hospital discharge until the first discharge diagnosis of infection, thromboembolism, death, or end of study, whichever occurred first. The time to develop infection, thromboembolism, or malignancy (i.e., latency) was estimated by subtracting the date of discharge from the first hospitalization listing a splenectomy from the date of the first hospitalization listing a diagnosis of infection, thromboembolism, or malignancy. To minimize the influence of reverse causality (i.e., undetected cancer requiring the splenectomy), all analyses were restricted to individuals with their first VA discharge with a splenectomy at least 1 year prior to the first hospitalization listing a diagnosis of cancer. Abbreviations: RR=relative risk; CI=confidence intervals 3.11-9.72 RR* models adjusted for attained age and calendar time, latency, race and number of visits. Kidney cancer also adjusted for hypertension. Buccal, esophagus and liver cancers also adjusted for alcohol. All study subjects were followed from one year after their initial hospital discharge until the first discharge diagnosis of infection, thromboembolism, death, or end of study, whichever occurred first. The time to develop infection, thromboembolism, or malignancy (i.e., latency) was estimated by subtracting the date of discharge from the first hospitalization listing a splenectomy from the date of the first hospitalization listing a diagnosis of infection, thromboembolism, or malignancy. To minimize the influence of reverse causality (i.e., undetected cancer requiring the splenectomy), all analyses were restricted to individuals with their first VA discharge with a splenectomy at least 1 year prior to the first hospitalization listing a diagnosis of cancer. Abbreviations: RR=relative risk; CI=confidence intervals .31 RR* models adjusted for attained age and calendar time, latency, race and number of visits. Kidney cancer also adjusted for hypertension. Buccal, esophagus and liver cancers also adjusted for alcohol. All study subjects were followed from one year after their initial hospital discharge until the first discharge diagnosis of infection, thromboembolism, death, or end of study, whichever occurred first. The time to develop infection, thromboembolism, or malignancy (i.e., latency) was estimated by subtracting the date of discharge from the first hospitalization listing a splenectomy from the date of the first hospitalization listing a diagnosis of infection, thromboembolism, or malignancy. To minimize the influence of reverse causality (i.e., undetected cancer requiring the splenectomy), all analyses were restricted to individuals with their first VA discharge with a splenectomy at least 1 year prior to the first hospitalization listing a diagnosis of cancer. Abbreviations: RR=relative risk; CI=confidence intervals
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